Summary
Ventilator-associated pneumonia (VAP) continues to be a clinically important hospital-acquired infection. In this paper, Marin H. Kollef discusses the financial impact.
Ventilator-associated pneumonia prevention. Is It worth It?
https://www.atsjournals.org/doi/full/10.1164/rccm.201504-0734ED
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now